This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pierre Fabre Medicament. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Cyrille Dreyfus: Innovator in Sulfomaleimide-based Linkers
Introduction
Cyrille Dreyfus is a notable inventor based in Amancy, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative linkers for drug conjugates. His work is aimed at enhancing the efficacy of cancer treatments.
Latest Patents
Cyrille Dreyfus holds a patent for "Sulfomaleimide-based linkers and corresponding conjugates." This invention relates to a linker of a specific formula, as well as linker-drug conjugates and binding unit-drug conjugates, including antibody-drug conjugates. These innovations are crucial for creating pharmaceutical compositions that can be used in cancer treatment.
Career Highlights
Dreyfus is associated with Pierre Fabre Medicament, a company known for its commitment to research and development in the pharmaceutical sector. His work has contributed to advancements in targeted therapies, which are essential for improving patient outcomes in oncology.
Collaborations
Cyrille Dreyfus has collaborated with notable colleagues such as Michel Perez and Frédéric Marion. These partnerships have fostered a collaborative environment that enhances innovation and research in drug development.
Conclusion
Cyrille Dreyfus is a prominent figure in the field of pharmaceutical innovation, with a focus on sulfomaleimide-based linkers that have the potential to revolutionize cancer treatment. His contributions continue to impact the industry positively.